BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30
• 31

• Drug Development

  Pivotal Phase 3 Study Of GlaxoSmithKline Shingles Candidate Vaccine Meets Its Primary Endpoint

  December 18, 2014

   · 

  5 min read
• Drug Development

  Pfizer Reports Top-Line Results From A Phase 3 Study Evaluating Pregabalin Controlled-Release Formulation As A Treatment For Patients With Postherpetic Neuralgia

  December 18, 2014

   · 

  9 min read
• FDA

  Eli Lilly’s CYRAMZA (ramucirumab) Receives Third FDA Approval

  December 18, 2014

   · 

  21 min read
• Business

  MonoSolRx LLC Names A. Mark Schobel Chief Innovation & Technology Officer; Keith Kendall Assumes Role Of CEO

  December 18, 2014

   · 

  2 min read
• Business

  Chimerix, Inc. Appoints Ronald C. Renaud, Jr. To Board Of Directors

  December 18, 2014

   · 

  3 min read
• Policy

  Successful FDA Inspection At Hovione

  December 18, 2014

   · 

  2 min read
• Business

  Dr. Michael A Ross, MD, Appointed As CEO Of Euclid Systems Corporation

  December 18, 2014

   · 

  2 min read
• Business

  Chimerix, Inc. And ContraVir Pharmaceuticals Establish Strategic Collaboration For Antiviral Drug Candidate CMX157

  December 18, 2014

   · 

  5 min read
• Business

  RedHill Biopharma Ltd. Acquires Technology From University of Minnesota As Part Of Ongoing RHB-104 Phase 3 Crohn’s Program

  December 18, 2014

   · 

  8 min read
• Drug Development

  TetraLogic Pharmaceuticals Announces Initiation Of A Randomized Phase 2 Clinical Trial Of SHAPE In Subjects With Cutaneous T-Cell Lymphoma

  December 18, 2014

   · 

  3 min read